Aptinyx Inc (NQ: APTX )

2.460 USD UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist

Price and Volume

Volume	181,857
Open	2.410
Bid (Size)	2.400 (2)
Ask (Size)	2.550 (9)
Prev. Close	2.460
Today's Range	2.410 - 2.540
52wk Range	2.300 - 6.470
Shares Outstanding	66,889,625
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors

May 10, 2021

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the election of Joan...

Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

April 29, 2021

Performance

YTD	-28.49%	-28.49%
1 Month	-13.99%	-13.99%
3 Month	-38.35%	-38.35%
6 Month	-22.40%	-22.40%
1 Year	-35.09%	-35.09%

More News

Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week

April 24, 2021

Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting

April 29, 2021

Aptinyx to Participate in Upcoming Conferences

April 27, 2021

3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021

April 11, 2021

Stocks That Hit 52-Week Lows On Wednesday

May 05, 2021

Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies

April 06, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

April 06, 2021

Aptinyx Stock Is Trading Higher After Restarting NYX-458 Study In Dementia Associated Cognitive Impairment

April 06, 2021

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

May 12, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.